Once-daily Belviq NDA coming later this year
This article was originally published in Scrip
Executive Summary
Eisai and Arena Pharmaceuticals said on 10 April they plan to seek the FDA's blessing later this year for their new drug application for an once-daily extended-release version of their weight-loss drug Belviq (lorcaserin).